Source:http://linkedlifedata.com/resource/pubmed/id/21183275
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-17
|
pubmed:abstractText |
Thyroid hormones (TH) - 3,5,3'-triiodo-L-thyronine (T?) and l-thyroxine (T?) - are important regulators of differentiation, growth, metabolism, and physiological function in most tissues. TH have been also implicated in cellular transformation, tumorigenesis and metastasis, assuming particular importance in tumor induced angiogenesis. TH-induced angiogenesis is thought to be initiated at integrin ?v?3 membrane receptor mainly through T? binding. The reduction of TH in circulation or the inhibition of TH actions at the integrin ?v?3 receptor would consequently produce a reduction on the proliferative and angiogenic TH effects. Therefore, targeting TH actions could be an alternative adjuvant therapy against cancer proliferation and angiogenesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alphaVbeta3,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thyroid Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vascular Endothelial...,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroid Hormones
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1872-7980
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
301
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-26
|
pubmed:meshHeading |
pubmed-meshheading:21183275-Animals,
pubmed-meshheading:21183275-Cell Proliferation,
pubmed-meshheading:21183275-Humans,
pubmed-meshheading:21183275-Integrin alphaVbeta3,
pubmed-meshheading:21183275-Models, Biological,
pubmed-meshheading:21183275-Neoplasms,
pubmed-meshheading:21183275-Neovascularization, Pathologic,
pubmed-meshheading:21183275-Receptors, Thyroid Hormone,
pubmed-meshheading:21183275-Receptors, Vascular Endothelial Growth Factor,
pubmed-meshheading:21183275-Thyroid Hormones
|
pubmed:year |
2011
|
pubmed:articleTitle |
Thyroid hormone as a regulator of tumor induced angiogenesis.
|
pubmed:affiliation |
Institute of Molecular Pathology and Immunology of the University of Porto, Portugal.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|